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Abstract: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic
syndrome. It affects 20%–30% of the US population, and it is increasing worldwide. Recently, the
role of lipid-rich maternal gestational nutrition in spurring the development of NAFLD among
offspring has been indicated. Fetal predisposition to NAFLD involves numerous physiological
reroutings that are initiated by increased delivery of nonesterified fatty acids to the fetal liver.
Hampered β-oxidation, uncontrolled oxidative stress, increased triacylglycerol synthesis, and
the endoplasmic reticulum unfolded protein response are all implicated in sculpting a hepatic
phenotype with a propensity to develop NAFLD in the postnatal state. This review suggests a
mechanism that integrates outcomes reported by a variety of studies conducted in an analysis
of fetal hepatic metabolic capacity amid the maternal consumption of a high-fat diet. Potential
preventive measures and therapies for use both as part of prenatal nutrition and for those at risk
for the development of NAFLD are also discussed.
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Over the last few decades, metabolic syndrome has become a pervasive epidemic in the
Western hemisphere, and perhaps surprisingly, this growth is not restricted to developed
countries.1 Metabolic syndrome consists of a collection of risk factors for cardiovascular disease, encompassing such conditions as obesity, diabetes, and hypertension.1
Epidemiologists are now witnessing a worldwide spread of metabolic syndrome due
to the industrialization of developing countries in conjunction with the globalization
of Western dietary preferences.1 In the US, the National Health and Nutrition Examination Survey compiled during the years of 2003–2006 showed that 34% of adults
over the age of 20 years met the criteria for metabolic syndrome, which is based on
the clinical evaluation of abdominal obesity, plasma triglycerides, blood pressure, and
fasting blood glucose levels.2 Recently, nonalcoholic fatty liver disease (NAFLD) has
been adopted as the hepatic manifestation of metabolic syndrome,3 and it is clinically
defined by triacylglycerol (TAG) storage exceeding 5% of the total liver mass.4
NAFLD affects an estimated 20%–30% of the US population, and 20% of those
affected will eventually develop nonalcoholic steatohepatitis (NASH). Once an individual has NASH, fibrosis is visible in the liver tissue, and the continued presence of
stressors may elicit the later emergence of cirrhosis or hepatocellular carcinoma.3,5
Although the etiology of NAFLD is poorly understood, a “two-hit hypothesis” was
proposed in 1998 by Day and James6 to describe the development of NAFLD and its
progression to NASH. According to this hypothesis, the first “hit” consists of hepatic
15
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insulin resistance or impaired β-oxidation of fatty acids, both
of which contribute to hepatic lipid accumulation. The second
“hit” consists of inflammation or oxidative stress, which may
aggravate the existing steatosis and drive progression into
NASH.6,7 Recently, it has been proposed that the first “hit”
can occur in utero due to a maternal diet that is high in fat.
Indeed, the offspring of such a condition have been shown to
have a three-fold increase in hepatic TAG shortly after birth.4,8
This predisposes the offspring to the adult development of
NAFLD, as only a second “hit” would be needed to spur the
development of steatohepatitis.
The current literature regarding the contribution of
prenatal nutrition to the development of NAFLD reveals
several distinct phenotypic alterations. This review seeks
to connect these seemingly disconnected outcomes into a
plausible sequence of events. The underlying questions that
this review addresses are: 1) in which ways does a lipid-rich
nutritional environment furnished by the mother interact with
the biochemical changes occurring within a developing fetus;
and 2) how may these interactions result in changes in gene
expression that contribute to an adult phenotype amenable
to TAG accumulation in the liver? As NAFLD continues to
extend its reach worldwide, seeking answers to these questions is essential.

Physiological background
In maternal circulation, plasma concentrations of nonesterified fatty acids (NEFAs) bound to albumin and TAG
contained within chylomicrons gradually elevate throughout
gestation.9 Placental uptake of NEFAs occurs either by diffusion or through a variety of fatty acid transport proteins.
For chylomicrons, the placenta expresses lipoprotein lipase,
which cleaves the contained TAG molecules into three NEFAs
and a glycerol molecule.9 The NEFAs are then free to diffuse
or be transported via a fatty acid transport protein into fetal
circulation.
Upon reaching the developing liver, NEFAs diffuse into
hepatocytes and they are rapidly converted into fatty acylcoenzyme A (CoA).10 Primarily, fatty acyl-CoAs enter the
mitochondria for β-oxidation. This is mediated by the ratelimiting enzyme, carnitine palmitoyltransferase 1 (CPT1),
which exchanges the bound CoA for carnitine – yielding
acyl-carnitine – which can then pass through the outer
mitochondrial membrane.11 Remaining NEFAs that do not
undergo β-oxidation will be stored by esterification at the
endoplasmic reticulum (ER) as TAG.12 TAG may be exported
within very low-density lipoproteins (VLDL), or TAG may
be stored within the hepatocyte cytosol in lipid droplets.13,14
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A lipid droplet is an organelle that functions to store TAG
within a phospholipid membrane comprised chiefly of
phosphatidylcholine (PC). Since NEFA accumulation is
toxic to hepatocytes,15 VLDL secretion and lipid droplet
formation can be regarded as protective measures against
hepatotoxicity.16
If the liver as a whole attains more fatty acids than it
eliminates via β-oxidation or VLDL secretion, TAG accumulates in lipid droplets,10 and this represents the defining
characteristic of NAFLD. In a model of lipid-rich prenatal
nutrition, the generalized pathway followed by NEFAs, as
described above, is perturbed in a manner that affects the
offspring’s physiology into adulthood, and induces a lifelong
predisposition for NAFLD.

Methods
Many of the studies reviewed here used mice as their model
organism and the researchers apportioned a maternal prenatal diet to one group of dams with a higher composition
of dietary lipids than that received by the control group.
Although not uniform amongst all studies, control groups
were fed a commercial “standard chow” diet containing
macronutrients distributed aptly for the nutritional needs of
mice. Increased consumption of dietary lipids is a frequent
nutritional misallocation in the common Western diet; hence,
what can be learned from these studies has the potential to
be readily implemented and appreciated.
However, a significant and inherent limitation of this
research is that increasing the quantity of one macronutrient
requires decreasing that of another. If the total percentage
of lipids increases, then the percentage of other nutrients
falls relative to the total - it is difficult to know whether the
experimental results can be attributed to an increase of one or
a decrease in another, or the combination. Additionally, it is
unlikely that an average “unbalanced” Western diet errs only
in its total composition of lipids. Although the implications
of a maternal high-fat (HF) diet explored in this review may
apply to those mothers who, for example, additionally have a
vitamin deficiency, whether there exists synergism or antagonism between certain dietary imbalances has yet to be explored
thoroughly, especially in the context of prenatal nutrition.

Disruptions resulting
from elevated β-oxidation
In a study by Bruce et al,17 the hepatic metabolic capacities of
four groups of mice that received either a HF or control (C)
prenatal and postnatal diet were analyzed. The groups were
designated as C/C, C/HF, HF/C, and HF/HF, in reference to
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their prenatal/postnatal nutrition.17 This study revealed that
levels of CPT1, which is the enzyme that mediates the transfer
of fatty acyl-CoA through the outer mitochondrial membrane
in the initiation of β-oxidation,11 did not differ among HF/C,
C/HF, and HF/HF mice, although all three of these groups
had marginally elevated CPT1 compared to the C/C group.17
This suggests that in the presence of increased cytosolic fatty
acids, there is an upper limit to the amount of CPT1 that can
be produced to accommodate the influx; CPT1 is the ratelimiting enzyme in this process.11
The increase in NEFAs in fetal circulation, which is a
result of the quantity of maternal dietary lipids, was met
with a corresponding slight escalation in fetal β-oxidation, as
described by Byrne et al.18 Strikingly, this study determined
that at 15 weeks of age, the HF/C and HF/HF groups exhibited
a 3.7- and 3.2-fold respective decrease in electron transport
chain (ETC) complex I activity compared to the C/C group,
and the C/HF group did not vary significantly from the C/C
group in this regard.18
Complex I of the ETC is notorious for the leakage of
reactive oxygen species (ROS) (Figure 1).19 Byrne et al18
hypothesize that increased ROS leakage from complex I, which
directly results from the increased rates of fetal β-oxidation,
causes mitochondrial deoxyribonucleic acid (mtDNA) damage. This could potentially reduce the postnatal mitochondrial
capacity for β-oxidation, as mtDNA lacks the shielding histone
structure that nuclear deoxyribonucleic acid (DNA) is afforded.18 Albeit reasonable, this explanation neglects to consider
the C/HF group’s unaffected complex I activity – if higher
β-oxidation is the initiating event that results in downstream
damage, as the authors assert, it remains unexplained why the
C/HF group did not display decreased ETC complex I activity
comparable to that of the HF/C and HF/HF groups.
Cytotoxic damage produced by sufficient ROS is often
referred to as oxidative stress. In several models of oxidative
stress, it has been demonstrated that a cell may selectively
shunt metabolites from the methionine cycle (Figure 2), down
the transsulfuration pathway at the expense of s-adenosylmethionine in order to increase the synthesis of glutathione
(GSH), a scavenger of ROS, in an effort to combat oxidative
stress.20,21 Independently, Bravo et al22 showed that in rats
fed a HF diet, expression of the enzymes cystathionine
β-synthase (CBS) and cystathionine γ-lyase, which participate in the transsulfuration pathway, were significantly
downregulated.22 CBS is a necessary enzyme that is involved
in the redirection of homocysteine from the methionine cycle
toward GSH synthesis, which occurs in the first step of the
transsulfuration pathway.21 In conjunction with pressure to
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generate GSH to neutralize ROS, homocysteine levels are
elevated (Figure 2).
Increased homocysteine levels lead to the downregulation
of many antioxidant enzymes,23 including GSH peroxidase 1,
by directly interfering with translation.24 In 2011, Zhang
et al25 determined that offspring of mice fed a HF diet during gestation had decreased expression of the antioxidant
enzymes GSH peroxidase 1, superoxide dismutase 1, and
paraoxonases 1, 2, and 3. Although this group did not suggest a reason for this downregulation, they did expound
upon the consequences of the resultant lowered threshold
for oxidative stress in the absence of adequate endogenous
defenses. It is possible that mild hyperhomocysteinemia,
due to the downregulation of CBS and the diversion of
methionine cycle metabolites down the transsulfuration
pathway, is responsible for the downregulation of antioxidant
enzymes, as noted by Zhang et al.25 In the study by Byrne18
discussed earlier, the mice fed a C diet in utero and a HF
diet postnatally (C/HF) did not display altered ETC complex
I activity, and it is possible that this is because their levels
of ROS-neutralizing antioxidant enzymes were not downregulated during development and, consequently, mtDNA
damage did not occur.

Disruptions resulting
from triacylglycerol storage
In hepatocytes, NEFAs that are not accommodated by CPT1
will be esterified to form TAG, which may be packaged into
a VLDL particle and exported, or they may be stored within
the cytosol of the hepatocyte in a lipid droplet.13,14 The storage of TAG within a hepatocyte may be precipitated by four
independent factors: 1) increased NEFAs in hepatocytes due
to increased delivery of NEFAs or de novo lipogenesis; 2)
increased rates of TAG synthesis; 3) reduced levels of VLDL
export; or 4) decreased capacity for β-oxidation.11 Given that
TAG accumulation exceeding 5% of the total liver weight is
the defining criterion for the presence of NAFLD set forth by
the American Association for the Study of Liver Diseases,4
presented here is a potential mechanism that connects excess
hepatocyte cytosolic NEFAs with the derailing of lipid synthesis regulation by the ER, resulting in the accumulation of
TAG within lipid droplets.
The ER produces acyl-CoA synthetase, which activates
NEFAs in the cytosol by converting NEFAs into fatty acylCoAs to allow for entrance into the ER, where the fatty
acyl-CoAs will serve as substrates for lipid synthesis.12
Furthermore, due to the increased delivery of cytoplasmic
NEFAs that results from a maternal lipid-rich diet, some of
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Fatty acid synthesis

β-oxidation

Acetyl-CoA
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NADH

ROS
ROS

Electron
transport chain

ROS
ROS
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Figure 1 Generalized pathway of lipid metabolism.
Notes: Cytoplasmic nonesterified fatty acids are rapidly converted to fatty acyl-CoA, which may proceed to undergo β-oxidation or serve as a substrate for either TAG
or phospholipid synthesis. Following β-oxidation, acetyl-CoA enters the tricarboxylic acid cycle; the produced NADH and FADH2 participate in the ETC. Complex I of the
ETC leaks injurious ROS.
Abbreviations: TAG, triacylglycerol; CoA, coenzyme A; TCA, tricarboxylic acid; NADH, nicotinamide adenine dinucleotide; FADH2, flavin adenine dinucleotide; ROS,
reactive oxygen species; ATP, adenosine triphosphatase; ETC, electron transport chain.

the TAG will be stored in lipid droplets adjacent to the ER.14
For reasons incompletely understood, sustained increases in
cytosolic NEFA concentration – and especially increases in
saturated NEFAs – beget ER stress and, subsequently, the
induction of the unfolded protein response (UPR) in both
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mice and in the yeast, Saccharomyces cerevisiae.26 The existing discussion of NEFA-induced ER stress in the literature
often elects to cover the downstream effects of ER stress,
rather than investigate the mechanism responsible for its
appearance; here, both will be addressed.
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Methionine

s-adenosylmethionine

s-adenosylhomocysteine
Adenosine
Homocysteine
Serine

Cystathionine β-synthase

Cystathionine
A-ketobutyrate

Cystathionase
Cysteine

Glutamine

γ-glutamylcysteine ligase

γ-glutamylcysteine
Glycine

Glutathione synthetase

Glutathione
Figure 2 The methionine cycle and transsulfuration pathway.
Notes: Glutathione synthesis begins with the conversion of homocysteine into
cystathionine, which is dependent on the presence of both serine and cystathionine
β-synthase. As the expression of cystathionine β-synthase is downregulated in
response to a high-fat diet, unconverted homocysteine may accumulate. Adapted
from Free Radical Biology and Medicine, 43(7), Hitchler MJ, Domann FE, An
epigenetic perspective on the free radical theory of development, 1023–1036,
Copyright 2007, with permission from Elsevier.20

When TAG is synthesized for storage in a lipid droplet,
this presents to the hepatocyte the additional challenge of
producing PC for the lipid droplet membrane.27 While the
ER membrane contains a specific ratio of PC and phosphatidylethanolamine (PE), the preferential phospholipid coat
for lipid droplets is PC; due to its properties as a surfactant,
PC maintains the integrity and prevents the coalescence
of adjacent lipid droplets. When PC is replaced with PE,
neighboring lipid droplets rapidly merge.28 Fu et al27 assert
that in order to produce PC, the genes Pemt and Pcyt1a are
activated. Pemt is a s-adenosylmethionine-dependent methyltransferase that converts existing PE into PC by way of
sequential methylation, and it is only significantly expressed
in the liver.27 Pcyt1a encodes the more ubiquitous synthesizer
of PC, CTP:phosphocholine cytidylyltransferase.29
Membrane composition is a determinant of many biophysical properties of a cell or an organelle,30 and upon
producing PC for lipid droplets, the specific PC/PE ratio in
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the ER membrane is threatened and may rise.15,28 Although
the mechanism is incompletely understood, an elevated PC/
PE ratio in the ER membrane causes spontaneous dysfunction
of sarco/ER calcium adenosine triphosphatase (SERCA), and
returning the ratio to its initial state improves SERCA function.31 SERCA maintains a significant calcium gradient; the
concentration of calcium within the ER is nearly 10,000 times
greater than in the cytoplasm.15 Proper SERCA function is
crucial not only for maintaining low cytosolic calcium for
the purpose of signaling events that may include a controlled
release of calcium, but it is also important because many of
the chaperone proteins in the ER lumen – such as binding
immunoglobulin protein (also known as GRP78), calreticulin,
and calnexin – are calcium-dependent.32,33 Impaired SERCA
function thus impedes the ability of calcium-dependent chaperones to properly fold proteins.34,35 Additionally, the increase
in cytosolic calcium concentration further aggravates mitochondria and contributes to additional oxidative stress.32
The accumulation of unfolded or misfolded proteins in the
ER lumen defines ER stress and activates the UPR, a series
of intracellular signaling events that function to restore ER
homeostasis.36 These events culminate in reducing the ability
of proteins to enter the ER for posttranslational modifications,
upregulation of chaperone proteins and, if homeostasis cannot be restored, apoptosis.15 ER stress and the UPR have two
implications that directly contribute to the predisposition of
offspring to NAFLD:
1. Upon induction of the UPR, activating transcription factor-6
(ATF6) – one of the proteins that participates in UPR intracellular signal transduction – is activated by intramembrane
proteolysis. ATF6 shares its proteolytic machinery with
sterol response element binding protein 1c (SREBP-1c),36
so upon cleavage of ATF6, SREBP-1c is also cleaved and
is able to translocate to the nucleus.37 SREBP-1c is a transcriptional activator for the lipogenic proteins, acetyl-CoA
carboxylase (ACC) and glucokinase.10
2. ER stress also activates the c-Jun N-terminus kinase (JNK)
pathway, which leads to the phosphorylation of certain serine residues in insulin receptor substrate-1 (IRS-1). Given
that the docking of IRS-1, the subsequent tyrosine phosphorylation, and the release of IRS-1 is a necessary occurrence
in successful insulin signaling, serine phosphorylation of
IRS-1 blocks signal transduction and contributes to hepatic
insulin resistance.38,39 Hepatic insulin resistance has been
independently demonstrated to overactivate SREBP-1c.40
SREBP-1c activates the transcription of ACC and
glucokinase, which both contribute to postnatal fatty
acid synthesis.10,37,40 However, the presence of both ACC
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and g lucokinase are complicated in a HF intrauterine
environment. ACC converts acetyl-CoA into malonyl-CoA
which, in addition to playing a key role in de novo lipogenesis,
is a potent inhibitor of CPT1 and thus decreases the rate of
β-oxidation (Figure 3).10 Additionally, it has been shown that
the fetal liver is more sensitive than the liver of a newborn to
the inhibitory effects of malonyl-CoA.9 In fact, in a maternal
HF diet experiment performed by Ashino et al,4 82-day-old
offspring of dams who consumed a diet deriving 45% of its
caloric value from nondescript fats had higher levels of activated ACC than did offspring of mice fed a control diet, which
indicates that the elevation of ACC persists in the postnatal
state. Since Nagle et al11 included decreased β-oxidation
as one of the four factors that directly contributes to TAG
accumulation in the liver, it is probable that malonyl-CoA
contributes to the predisposition of offspring to NAFLD.

Glucokinase participates in the first step of fatty acid
synthesis by phosphorylating glucose, resulting in glucose6-phosphate.41 Trophoblasts ordinarily express numerous
glucose transporters from maternal to fetal circulation, such
that glucose is readily available for the fetus.9 Additionally, it
has been demonstrated in a rodent model that the placentas of
mothers who consume a HF diet express a five-fold increase
in glucose transporter-1, which facilitates the diffusion of
glucose into the fetal circulation.42 The increased expression of
glucokinase in conjunction with an elevated influx of glucose
may additionally contribute to de novo lipogenesis.
As NEFAs are produced by the de novo lipogenesis, in
which both malonyl-CoA and glucokinase participate, and
since ER stress was initiated with excessive NEFAs entering the
ER for lipid synthesis, this process can be perceived as cyclic.
Certainly, the NEFAs produced by de novo lipogenesis could

Fetal
downregulation
of CBS

Synthesis of PC
for lipid droplets

Homocysteine
levels elevate

NEFA delivery to
fetal hepatic ER

ER PC:PE ratio
increases

SERCA
dysfunction

Maternal high-fat
gestational diet

Deficient
calcium
retention

Malonyl-CoA and
glucokinase drive
fatty acid
synthesis

ER stress,
induction of
UPR

Shunting of
metabolites
toward transsulfination
pathway to
produce GSH

Downregulation
of antioxidant
enzymes

Oxidative stress

Fetal hepatic
β-oxidation of
fatty acyl-CoA

Increased
production of
ROS

SREBP-1c
cleaved, JNK
activation
Figure 3 Sequence of physiological changes resulting from a maternal lipid-rich diet.
Notes: The left cycle demonstrates how NEFA activation and packaging by the ER results in ER stress, which then spurs the activation of fatty acid synthesis – as part of
de novo lipogenesis – and synthesized fatty acids may be taken up again by the ER for TAG synthesis. Cytosolic calcium agitates mitochondria and contributes to additional
oxidative stress, in addition to the stress that results from β-oxidation, visible on the right.32
Abbreviations: PC, phosphatidylcholine; CBS, cystathionine β-synthase; ER, endoplasmic reticulum; PE, phosphatidylethanolamine; NEFA, nonesterified fatty acid;
SERCA, sarco/endoplasmic reticulum calcium adenosine triphosphatase; GSH, glutathione; UPR, unfolded protein response; CoA, coenzyme A; SREBP-1c, sterol regulatory
element-binding protein 1c; JNK, Janus kinase; ROS, reactive oxygen species; TAG, triacylglycerol.
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instead undergo β-oxidation, but as their synthesis requires
nicotinamide adenine dinucleotide phosphate,9 this would
be more energetically expensive than to reserve β-oxidation
for exogenous, maternally-derived NEFAs. Additionally, the
inhibition of β-oxidation by malonyl-CoA, and the potential
mtDNA damage caused by rampant ROS, both encourage the
continuation of NEFAs in the cycle.

Management of NAFLD: prenatal
and postnatal, present and future
Given the multifaceted nature of TAG accumulation borne
in utero, it may seem likely that many opportunities exist for
therapeutic interjection. Presently, omega-3 polyunsaturated
fatty acids (n-3 PUFAs) and genistein have evidence to support
their intake as part of preventative maternal prenatal nutrition.
Novak et al43 performed a study whereby two groups of dams
were fed the same total amount of dietary fat, but the composition of dietary fats differed between the groups. Each received
different fats but both had the same total amount of dietary fat.
On postnatal day 3, the offspring of the group that received
adequate n-3 PUFAs displayed higher levels of proteins that
were integral to mitochondrial β-oxidation, including CPT1,
and they downregulated genes associated with fatty acid synthesis, compared to the group that received inadequate n-3
PUFAs.43 It appears that supplementation of n-3 PUFAs as part
of proper prenatal nutrition, which is reflective of this finding,
may be a possible preventative route for NAFLD. However, in
conflict with this proposition is evidence proposed by Dennery
in 2010,44 who claimed that maternal PUFA supplementation
causes oocyte mitochondria to increase their ROS production,
which leads to impaired embryonic development. In adults with
NAFLD, supplementation with docosahexaenoic acid, an n-3
PUFA, has been shown to reduce the rates of de novo lipogenesis via the negative regulation of SREBP-1c transcription.45
Perhaps a conciliatory solution lies in the timing of n-3 PUFA
supplementation; questions with such therapeutic potential
warrant additional investigation.
Genistein, a soy isoflavone found in soybeans, has received
more consistent favorable literature reviews than n-3 PUFAs.
When provided concurrently with a maternal HF diet and
comprising 0.2% (by weight) of total maternal nutrition, the
offspring displayed significantly less hepatic TAG accumulation and elevated levels of GSH when compared to offspring
that solely received a maternal HF diet.46 As GSH production is regulated in response to ROS levels, it is possible that
genistein supplementation ameliorated these defenses and
prevented the downstream hepatotoxic effects of uncontrolled
ROS. Additionally, in an adult HF feeding study conducted by
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Ji et al,47 genistein supplementation embodied the qualities of
an anti-inflammatory compound and appreciably decreased
the serum levels of the cytokines, tumor necrosis factor-alpha
and interleukin 6. As inflammation provides the “second hit”
that drives the transition from NAFLD into NASH, the antiinflammatory effects of genistein may prevent or attenuate
the development of NASH. Ji et al47 also noted that genistein
is a tyrosine kinase inhibitor, and they implicated this characteristic as the cause of the marked inhibition of the JNK
pathway observed in response to genistein supplementation.
Activation of the JNK pathway is implicated in the development of hepatic insulin resistance and subsequent overactivation of SREBP-1c.39,40 Preventing these outcomes in utero by
supplementing the prenatal diet with genistein may improve
the offspring’s hepatic phenotype. It is also encouraging that
these improvements in inflammation occurred in the postnatal
environment, as they represent a potential degree of reversibility for those born at risk for the development of NAFLD.
Certainly with the number of factors that contribute to the
development of NAFLD, additional therapeutic avenues for
preventing TAG accumulation have yet to be discovered. An
experimental approach of conjugating the lipophilic cation,
triphenylphosphonium, to an antioxidant such as vitamin E or
ubiquinone has been shown to permit the delivery of the antioxidant moiety through the mitochondrial membrane.48,49 When this
approach was described by Murphy and Smith in 2007,48 it was
their intention to employ the lipophilicity of triphenylphosphonium to ensure diffusion of the antioxidant into the mitochondria,
where ROS neutralization is most useful in relegating oxidative
stress. Recently, Finichiu et al49 confirmed that this form of antioxidant delivery does indeed reach mitochondria in the tissues
with high levels of oxidative stress. Although this mechanism
has only been investigated in general models of oxidative stress,
given the role of ROS in the development of NAFLD, future
advances may render this an applicable method of antioxidant
delivery for those affected by NAFLD.
There is a need for a clearly defined, ideal prenatal diet
that considers the negative implications of the HF diet discussed here, and there is also the need for a diet for those
affected by NAFLD. The American Dietetic Association
does not currently suggest a recommended daily allowance
of fats for pregnant women.50 Current research is exploring
many different diet and exercise regimes for those living
with NAFLD, with mixed results.51,52 Future work needs to
ascertain the maximum daily allowance for dietary fats when
undesirable outcomes for the fetus arise. This will allow for
the development of dietary guidelines that could easily be
followed by expecting mothers.
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The diagnostic approach to NAFLD in childhood has
recently been developed by the European Society of Paediatric
Gastroenterology, Hepatology, and Nutrition committee.53
The gold standard for the detection of NAFLD is through liver
biopsy, but this should only be performed after less invasive
procedures to rule out other conditions. Testing for appropriate biomarkers and imaging by magnetic resonance imaging
or ultrasound are noninvasive and fairly reliable diagnostic
tools for adults and older children, and these methods may
also be developed for infants.

Conclusion
Education aimed at promoting a balanced prenatal diet
may be an effective intervention in convincing expecting
mothers to consider nutrition as equally important to the
health of a fetus as abstaining from tobacco use and alcohol
consumption. Previous efforts to educate women on the harmful consequences of these activities during pregnancy have
been met with success.9 A voluntary decrease in smoking and
drinking alcohol by pregnant women was demonstrated following these efforts, which was indicative of a willingness by
women to modify their lifestyle for the benefit of their babies.9
As the metabolic syndrome has garnered significant attention
from public health organizations in Western countries, the
recent acceptance of NAFLD as the hepatic manifestation of
metabolic syndrome will likely spur its inclusion in future
public health educational efforts.
Of adults who present with NAFLD, most display significant mtDNA abnormalities and mutations, and it has
been estimated that about 26% of hepatic TAG in NAFLD
patients is derived from de novo lipogenesis.10,21 In the context
of elevated maternal dietary lipids, it is clear that both de
novo lipogenesis and esterification of delivered NEFAs are
encouraged in the fetus via multiple mechanisms discussed
herein: damaged mtDNA and associated reduced capacity for
β-oxidation; the inhibition of CPT1 by malonyl-CoA; and
the inadvertent activation of SREBP-1c during the unfolded
protein response. The resultant phenotype of the offspring
whose mothers consumed a lipid-rich diet during pregnancy
shares many commonalities with that of adult NAFLD, and
as illustrated in this review, it predisposes offspring for the
later development of NAFLD.
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